STAAR Surgical Company Reports 15% Fourth Quarter Revenue Growth And 13% Full Year 2013

MONROVIA, Calif., Feb. 26, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported revenue for the fourth quarter ended January 3, 2014 of $18.9 million, a 15% increase over $16.5 million reported for the fourth quarter of 2012. The effect of foreign currency exchange reduced sales by $1.1 million during the quarter. On a constant currency basis, revenues grew 22% during the fourth quarter of 2013 compared to the fourth quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.